Compare SLDB & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | ASIX |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.6M | 527.0M |
| IPO Year | 2017 | 2016 |
| Metric | SLDB | ASIX |
|---|---|---|
| Price | $8.33 | $23.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | $16.36 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 1.0M | 450.0K |
| Earning Date | 05-14-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | ★ 34.97 | 11.11 |
| EPS | N/A | ★ 1.80 |
| Revenue | $8,094,000.00 | ★ $1,684,625,000.00 |
| Revenue This Year | N/A | $4.19 |
| Revenue Next Year | N/A | $4.60 |
| P/E Ratio | ★ N/A | $12.97 |
| Revenue Growth | N/A | ★ 45.49 |
| 52 Week Low | $2.45 | $14.10 |
| 52 Week High | $8.87 | $25.94 |
| Indicator | SLDB | ASIX |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 52.81 |
| Support Level | $5.16 | $20.28 |
| Resistance Level | $8.47 | $25.74 |
| Average True Range (ATR) | 0.62 | 0.93 |
| MACD | 0.06 | -0.30 |
| Stochastic Oscillator | 72.18 | 5.79 |
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.